Osteopetrosis, literally bone becoming stone and also called marble bone disease or Albers-Schönberg disease, is an extremely rare inherited disorder in which the bones become abnormally hard and dense because the osteoclasts, the cells responsible for breaking down old bone tissue, fail to develop or function properly, unlike osteoporosis in which the bones become weak. The condition follows autosomal dominant, autosomal recessive or, less commonly, X-linked recessive inheritance patterns depending on which gene is affected. Despite the excess bone formation, the resulting bone is paradoxically more brittle than normal bone and fractures more easily. Mild forms may cause no noticeable symptoms, but severe forms can produce stunted growth, anemia, recurrent infections and neurological complications such as blindness, facial paralysis and deafness caused by the extra bone pressing on nerves as they pass through narrowed skull openings.
Facts
Classification
ICD-10 ChapterXVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 2 Communicable or Non-communicable Causative Agent
Causative Agent (category) First Described Connections
Treated By
Source ChEMBL, EMBL-EBI: Interferon gamma-1b approved indications (ChEMBL)
Sources
1. Osteopetrosis (Wikipedia)
lead sentence 1
Osteopetrosis, literally 'bone becoming stone', also known as marble bone disease or Albers-Schönberg disease, is an extremely rare inherited disorder whereby the bones harden, becoming denser, in contrast to more prevalent conditions like osteoporosis, in which the bones become less dense and more brittle, or osteomalacia, in which the bones soften.
Lead: disease category
Osteopetrosis, literally 'bone becoming stone', also known as marble bone disease or Albers-Schönberg disease, is an extremely rare inherited disorder whereby the bones harden, becoming denser, in contrast to more prevalent conditions like osteoporosis, in which the bones become less dense and more brittle, or osteomalacia, in which the bones soften.
Article text
Osteopetrosis was first described in 1903 by German radiologist Albers-Schönberg.
View the Source2. World Health Organization: ICD-10 Version:2019 - Q78.2
World Health OrganizationICD-10 2019 category Q78.2, Chapter XVIIQuote, ICD-10 2019 category Q78.2, Chapter XVII
Q78.2 Osteopetrosis
View the Source ChEMBL, EMBL-EBI: Interferon gamma-1b approved indications (ChEMBL)
ChEMBL, EMBL-EBITreated By: Interferon gamma-1b, drug_indication record, maximum phase 4, MeSH heading OsteopetrosisQuote, Treated By: Interferon gamma-1b, drug_indication record, maximum phase 4, MeSH heading Osteopetrosis
"max_phase_for_ind": "4.0", "mesh_heading": "Osteopetrosis", "molecule_chembl_id": "CHEMBL1201564"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.